• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Differentiation of COVID-19 from other types of viral pneumonia and severity scoring on baseline chest radiographs: Comparison of deep l

tetano

Editor, Senior Moderator
PLoS One


. 2025 Jul 29;20(7):e0328061.
doi: 10.1371/journal.pone.0328061. eCollection 2025. Differentiation of COVID-19 from other types of viral pneumonia and severity scoring on baseline chest radiographs: Comparison of deep learning with multi-reader evaluation

Nastaran Enshaei[SUP] 1 [/SUP], Arash Mohammadi[SUP] 1 [/SUP], Farnoosh Naderkhani[SUP] 1 [/SUP], Nick Daneman[SUP] 2 [/SUP], Rawan Abu Mughli[SUP] 3 [/SUP], Reut Anconina[SUP] 3 [/SUP], Ferco H Berger[SUP] 3 [/SUP], Robert Andrew Kozak[SUP] 4 [/SUP], Samira Mubareka[SUP] 5 [/SUP], Ana Maria Villanueva Campos[SUP] 3 [/SUP], Keshav Narang[SUP] 3 [/SUP], Thayalasuthan Vivekanandan[SUP] 3 [/SUP], Adrienne Kit Chan[SUP] 2 [/SUP], Philip Lam[SUP] 2 [/SUP], Nisha Andany[SUP] 2 [/SUP], Anastasia Oikonomou[SUP] 3 [/SUP]



Affiliations
Abstract

Chest X-ray (CXR) imaging plays a pivotal role in the diagnosis and prognosis of viral pneumonia. However, distinguishing COVID-19 CXRs from other viral infections remains challenging due to highly similar radiographic features. Most existing deep learning (DL) models focus on differentiating COVID-19 from community-acquired pneumonia (CAP) rather than other viral pneumonias and often overlook baseline CXRs, missing the critical window for early detection and intervention. Moreover, manual severity scoring of COVID-19 CXRs by radiologists is subjective and time-intensive, highlighting the need for automated systems. This study introduces a DL system for distinguishing COVID-19 from other viral pneumonias on baseline CXRs acquired within three days of PCR testing, and for automated severity scoring of COVID-19 CXRs. The system was developed using a dataset of 2,547 patients (808 COVID-19, 936 non-COVID viral pneumonia, and 803 normal cases) and validated externally on several publicly accessible datasets. Compared to four experienced radiologists, the model achieved higher diagnostic accuracy (76.4% vs. 71.8%) and enhanced COVID-19 identification (F1-score: 74.1% vs. 61.3%), with an AUC of 93% for distinguishing between viral pneumonia and normal cases, and 89.8% for differentiating COVID-19 from other viral pneumonias. The severity-scoring module exhibited a high Pearson correlation of 93% and a low mean absolute error (MAE) of 2.35 compared to the radiologists' consensus. External validation on independent public datasets confirmed the model's generalizability. Subgroup analyses stratified by patient age, sex, and severity levels further demonstrated consistent performance, supporting the system's robustness across diverse clinical populations. These findings suggest that the proposed DL system could assist radiologists in the early diagnosis and severity assessment of COVID-19 from baseline CXRs, particularly in resource-limited settings.


 
Back
Top Bottom